Authors:
BLACK DM
BAKKERARKEMA R
HEINONEN T
NAWROCKI JW
Citation: Dm. Black et al., EFFICACY AND SAFETY OF ATORVASTATIN IN HYPERLIPIDEMIC PATIENTS WITH CONCURRENT HYPERTENSION OR NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of hypertension, 16, 1998, pp. 31018-31018
Authors:
BLACK D
DAVIDSON M
KOREN M
BAKKERARKEMA R
TRESH P
MCLAIN R
SMITH D
HUNNINGHAKE D
Citation: D. Black et al., COST-EFFECTIVENESS OF TREATMENT TO NATIONAL CHOLESTEROL EDUCATION PANEL (NCEP) TARGETS WITH HMG-COA REDUCTASE INHIBITORS - TRIAL DESIGN, PharmacoEconomics, 12(2), 1997, pp. 278-285
Authors:
DAVIDSON M
MCKENNEY J
STEIN E
SCHROTT H
BAKKERARKEMA R
FAYYAD R
BLACK D
Citation: M. Davidson et al., COMPARISON OF ONE-YEAR EFFICACY AND SAFET Y OF ATORVASTATIN VERSUS LOVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA, Perfusion, 10(10), 1997, pp. 344-352
Authors:
DAVIDSON M
MCKENNEY J
STEIN E
SCHROTT H
BAKKERARKEMA R
FAYYAD R
BLACK D
Citation: M. Davidson et al., COMPARISON OF ONE-YEAR EFFICACY AND SAFETY OF ATORVASTATIN VERSUS LOVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA, The American journal of cardiology, 79(11), 1997, pp. 1475-1481